Skip to main content
. 2017 Oct 9;8(56):96089–96102. doi: 10.18632/oncotarget.21716

Table 1. Summary of reported direct AMPK activators.

Compounds Chemical structure Binding subunit Cell line Effect time Effect concentration Reference
Salicylate graphic file with name oncotarget-08-96089-i001.jpg β A549 48 h 103.64 ± 4.59 μM [74]
A-769662 graphic file with name oncotarget-08-96089-i002.jpg β A549 48 h 10 μM [13]
Compound 991 graphic file with name oncotarget-08-96089-i003.jpg α
β
AML 48 h 100 μM [65] [63]
MT 63–78 graphic file with name oncotarget-08-96089-i004.jpg β PC3 48 h 25-50 μM [75]
PT-1 graphic file with name oncotarget-08-96089-i005.jpg α
γ
HelaHEK293 6 h1 h 20-40 μM100 μM [66][67]
OSU-53 graphic file with name oncotarget-08-96089-i006.jpg α MDA-MB-231/MDA-MB-468 72 h24-72 h 5 μM5-10 μM [71][69]
Compound-13 graphic file with name oncotarget-08-96089-i007.jpg α Mouse hepatocytesGastric epithelial cells 3 h24 h 10-100 μM10 μM [72][73]
CNX-012-570 Not shown β HepG2/C2C12, 3T3L1 2-4 h 0.3 μM [76]